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• Human oRGs are an additional source to generate OPCs through Pre-OPCs 
• Pre-OPCs express EGFR and undergo a hybrid mitotic somal translocation during 
division 
• OPCs undergo consecutive symmetric divisions to exponentially increase the 
progenitor cell pool 







The human cerebral cortex has enlarged greatly during evolution, with expanded grey and 
white matter volumes. While increased progenitor diversity and enhanced proliferative potential 
play important roles in human neurogenesis and grey matter expansion, the mechanisms of 
human oligodendrogenesis and white matter expansion remain largely unknown. Here we 
identify novel EGFR-expressing intermediate progenitor cells (Pre-OPCs) that originate from 
outer radial glial cells (oRGs) and undergo mitotic somal translocation (MST) during division. 
They produce oligodendrocyte precursor cells (OPCs), providing an additional source of 
human cortical OPCs and defining a unique trajectory of oligodendrogenesis. We further 
demonstrate that OPCs undergo consecutive symmetric divisions to exponentially increase the 
progenitor cell pool. Finally, we find that the OPC enriched gene, PCDH15, mediates daughter 
cell repulsion and facilitates proliferation. These findings indicate properties of OPC derivation, 




outer radial glia (oRG), intermediate progenitor cell (IPC), oligodendrocyte precursor cell 




Cerebral white matter has enlarged dramatically during evolution, associated with a significant 
increase in myelinating oligodendrocytes which are the major white matter cell type (Zhang 
and Sejnowski, 2000; Simons and Nave, 2015). However, most of our knowledge of 
oligodendrocyte development is derived from animal studies (Fancy et al., 2011; Bergles and 
Richardson, 2015; Emery and Lu, 2015) and relatively little is known about the distinct features 
of human oligodendrocyte production and how its regulation contributes to human white matter 
expansion.  
 
In rodents, oligodendrocytes arise from the differentiation of oligodendrocyte precursor cells 
(OPCs), which are derived from embryonic progenitors near the ventricle (Warf et al., 1991; 
Pringle and Richardson, 1993; Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al., 2005). In 
the mouse forebrain, OPCs are generated in three successive waves from the ganglionic 
eminences and the cortical ventricular zone (Kessaris et al., 2006). In the human brain, the first 
PDGFRA-expressing OPCs appear around 10 gestational weeks (GW10). Their numbers 
increase at GW15 and are mainly found in the ganglionic eminences and cortical germinal 
zones, reflecting an evolutionary conservation of OPC production at sites surrounding the 
ventricles (Jakovceviki and Zecevic, 2005; Rakic and Zecevic, 2003; Mo and Zecevic, 2009). 
However, primates develop an enlarged cortical germinal zone, the outer subventricular zone 
(OSVZ), which is lacking in most rodents (Smart et al., 2002; Zecevic et al., 2005; Fish et al., 
2008), and diverse progenitors in the OSVZ contribute to neurogenesis and the enlargement of 
the human cerebral cortex (Betizeau et al., 2013; Nonako-Kinoshita et al., 2013). It is unclear 
whether there are any additional progenitor sources of human OPC production associated with 
white matter expansion and how human OPCs enhance oligodendrocyte production to match 
the increase demands for myelination.  
 
Here we investigate the origin of human cortical OPCs and characterize the trajectory of OPC 
production. Combining single-cell RNA-sequencing (scRNA-seq), immunohistochemistry, 
immunopanning, primary cell and brain slice culture, as well as time-lapse imaging, we identify 
a novel intermediate progenitor cell type, the EGFR-expressing Pre-OPC, present at the onset 
of gliogenesis in the OSVZ. These highly proliferative cells exhibit unique dividing dynamics 
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characterized by a diminutive mitotic somal translocation (MST) and produce OPCs. We also 
provide evidence that outer radial glial cells (oRGs) support oligodendrogenesis, providing an 
extra source of OPC production in the human cortex that has not been observed in rodents. 
We further demonstrate that human OPCs in the OSVZ undergo frequent consecutive 
symmetric divisions to amplify progenitor cell number exponentially and describe a unique 
repulsive behavior between OPC daughter cells mediated by the OPC-enriched gene 
PCDH15. The latter serves to avoid local OPC accumulation and facilitate OPC proliferation. 
These findings highlight a novel oligodendrocyte lineage in the human brain with enhanced 
precursor proliferation and a mechanism for cell dispersion, deepening our understanding of 
human oligodendrogenesis and cortical expansion. 
 
RESULTS 
Transcriptional Profiles of OPCs in the Developing Human Cortex 
In order to study the diversity and developmental trajectories of human OPCs, we sought to 
survey their transcriptional profiles in the developing cortex by scRNA-seq (Figure 1A). We 
previously applied scRNA-seq to generate a census of the main cell types in the developing 
human cortex, including neural progenitor cells (NPC), intermediate progenitor cells (IPC), 
neurons, astrocytes, oligodendrocytes, microglia, and endothelial cells (Nowakowski et al., 
2017).  However, among the 4,261 unbiased captured cells, only 40 were OPCs (Figure 1B), 
possibly due to low abundance during the late first and second trimester and high fragility. 
 
Unlike studies in mouse, where transgenic lines and fluorescence-activated cell sorting (FACS) 
of GFP labeled OPCs (eg: PDGFRA-H2B-GFP) have been used for scRNA-seq (Marques et 
al., 2016 and 2018), a transgenic strategy is not possible with human samples. To study 
human OPCs during the onset of gliogenesis, we leveraged immunopanning techniques 
(Dugas and Emery, 2013; Barres, 2014) to enrich for OPCs (Figure 1A). Primary cortical cells 
were dissociated from nine brain samples at GW20-GW24 and cells expressing PDGFRA 
were collected using PDGFRA-antibody coated petri dishes. Post-staining showed that most of 
the immunopanned cells were PDGFRA+NKX2-2+ and scRNA-seq showed that the majority of 
the immunopanned cells expressed PDGFRA mRNA (Figure 1C), indicating high efficiency of 
OPC enrichment. When we combined these PDGFRA-immunopanned cells with our previous 
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4,261 unbiased captured cells and clustered them by principle component analysis (PCA) and 
Louvain-Jaccard clustering, a total of 980 high quality cells were characterized as OPCs 
according to their RNA profiles (Figure 1D). Differential gene expression analysis showed that 
these cells expressed conventional OPC genes OLIG1, OLIG2, PDGFRA, NKX2-2, SOX10, 
S100B, and APOD (Figure 1E). Conversely, they did not express neuronal lineage genes 
EOMES, PPP1R17, NEUROD2, or NEUROD6, and were also well separated from clusters of 
IPCs, excitatory neurons (EN), and interneurons (IN) (Figure 1F). 
 
The OPCs were clustered into four groups (clusters 14, 2, 20, and 11). Metadata annotation 
showed that cortical OPCs acquired by unbiased-capture were mixed evenly with OPCs 
enriched by PDGFRA-immunopanning and major groups were composed of cells from multiple 
individuals (Figure 2A), indicating minimal effects of technical artifacts and batch differences. 
Cluster 20 included the largest number of PDGFRA-immunopanned cells (Figure 2A) and 
cluster 11 expressed cell cycling genes MKI67, ASPM, TOP2A, and CDK1, indicating that 
these OPCs were actively dividing (Figure 2B). Cluster 2 was close to cluster 20 based upon 
gene expression similarity analysis, so these two clusters might reflect OPCs at different 
maturation states.  
 
Interestingly, we found that cluster 14 expressed low levels of NPC genes, including GFAP, 
VIM, NES, HES1, NOTCH2, and EGFR (Figure 2B). In contrast, oligodendrocyte lineage 
genes OLIG1, OLIG2, and PDGFRA were also relatively low in this cluster compared with 
other OPC clusters, and later stage OPC genes like NKX2-2, SOX10 and APOD were not 
expressed (Figure 2B). Metadata analysis showed that cluster 14 was mainly composed of 
cells micro-dissected from the cortical germinal zone (Cortex-VZ/SVZ) (Figure 2A). Similarity 
analysis indicated that cluster 14 was closely related to both NPCs and OPCs (Figure 2C), 
suggesting a transitional Pre-OPC stage from multi-potent NPCs to lineage committed OPCs. 
This was supported by a trajectory reconstruction based upon our scRNA-seq by monocle 
(Trapnell et al., 2014; Qiu et al., 2017) (Figure 2D and 2E). According to the pseudo-lineage 
tree, VIM-expressing NPCs could generate EOMES-expressing IPCs that further differentiate 
into NEUROD6-expressing neurons. However, a branch point just prior to neurogenic IPC 
generation suggested that NPCs could also generate Pre-OPCs that further differentiated into 
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other OPC clusters (Figure 2D). Feature plots showed NPC genes like VIM and GFAP were 
down-regulated upon lineage commitment, while OPC genes like PDGFRA and APOD were 
up-regulated (Figure 2E). Together, our scRNA-seq analysis suggests a local intermediate 
progenitor source supporting OPC generation in the human cortex. 
 
EGFR-expressing Cells as Novel Intermediate Progenitors for Oligodendrogenesis 
ScRNA-seq analysis has indicated that mouse oligodendrocytes progress through various 
stages of differentiation (Marques et al., 2016 and 2018), but the progenitor types and 
developmental trajectory that generate OPCs prior to lineage commitment remain unclear. We 
were also interested in exploring any potential links between neurogenesis and 
oligodendrogenesis. In order to address these questions, we first used immunohistochemistry 
to characterize OPCs in second trimester fixed human cortical brain sections (Figure S1). We 
found that PDGFRA+OLIG2+ OPCs were present in low numbers across all cortical laminae 
and were distributed radially from the ventricular zone (VZ) to the cortical plate (CP) during 
middle to late stages of neurogenesis (GW16 and GW18). The number of OPCs increased 
dramatically after GW20, and continued to increase at GW24, the latest age we studied. 
 
We then evaluated cluster 14 OPCs by co-staining human cortical sections at GW20-24 for 
OPC and NPC markers. Most PDGFRA+OLIG2+ OPCs did not express NPC markers, but 
more than 10% of OPCs expressing low levels of PDGFRA and OLIG2 co-expressed NPC 
markers, NES, GFAP, VIM, and EGFR, reflecting an NPC signature (Figure 3A and S2). 
However, these EGFR+PDGFRA+ cells also expressed other OPC markers, OLIG1 and NG2, 
supporting a commitment to the oligodendrocyte lineage (Figure 3A). Moreover, the co-labeled 
cells had bipolar morphology, consistent with an immature OPC stage. Distribution analysis 
showed that most EGFR+PDGFRA+OLIG2+ cells were located in the OSVZ, though some were 
also present in the inner subventricular zone (ISVZ) and intermediate zone (IZ) (Figure S2). 
Considering their NPC and OPC marker co-expression, immature bipolar morphology, and 
germinal zone location, we reasoned that these cells might represent a transitional stage from 
NPCs to OPCs, consistent with our scRNA-seq data (Figure 2). 
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We next sought to determine the NPC subtypes that are capable of generating OPCs. 
Differential gene analysis based on scRNA-seq showed that EGFR was enriched in cluster 14 
(Figure 2B) and expressed in a subpopulation of NPCs (Figure 2E). In normal development, 
EGFR signaling regulates oligodendrogenesis and myelination in both juvenile and adult mice 
(Aguirre et al., 2007). Here, in late second trimester (GW20-24) at the onset of gliogenesis, we 
found a large population of EGFR+OLIG2+ cells in the germinal zones of the cortex. These 
cells were present in the cortex at low abundance at GW16 and GW18 but increased 
dramatically between GW20 and GW24 (Figure S3), coinciding with OPC generation (Figure 
S1). They were highly proliferative, with approximately 50% of EGFR+OLIG2+ cells expressing 
KI67 at GW20, and were mainly located in the OSVZ (Figure S3). The EGFR+ cells in the 
germinal zone also expressed NES and SOX2. We next asked whether the EGFR-expressing 
cells were subtypes of oRGs or IPCs, the two major types of neurogenic progenitors in the 
OSVZ. Unlike oRGs that exhibit a long radial process, EGFR-expressing cells were found 
randomly oriented in the germinal zone, being vertical, oblique or even horizontal to the 
ventricular surface (Figure S2-S4). Most EGFR+OLIG2+ cells did not express pS6 (Figure 3B), 
an oRG marker and a canonical readout of activated mTOR signaling (Nowakowski et al., 
2017). Conversely, most TNC+SOX2+ oRGs in the OSVZ did not express EGFR (Pollen et al., 
2015) (Figure 3B). These results suggest that EGFR labels a population of progenitor cells in 
the OSVZ separate from oRGs. Additionally, we found that the EGFR+OLIG2+ cells never 
expressed neurogenic IPC markers, such as EOMES or PPP1R17, suggesting a lineage 
separation between oligodendrocytes and neurons (Figure 3B). Taken together, our in vivo 
immunohistochemistry findings suggest a novel intermediate progenitor type abundant in the 
OSVZ during gliogenesis that expresses EGFR. 
 
We further tested whether the EGFR-expressing progenitors could generate OPCs. Cells were 
dissociated from the micro-dissected OSVZ at GW20 to GW24. OPCs were depleted from the 
cell suspension by two sequential rounds of PDGFRA- and O4-immunopanning to ensure that 
any OPCs produced later would be generated from precursor cells and not by OPC self-
renewal (Figure 3C). Progenitor cells were further enriched through positive selection by 
EGFR-immunopanning. The EGFR-expressing non-OPC cells were cultured in EGF containing 
medium for two days and then in PDGF containing medium for five additional days, and fixed 
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at two days in vitro (DIV2) or seven days in vitro (DIV7). At DIV2, 90-96% of the cells were 
EGFR+, suggesting high efficiency of the immunopanning-based enrichment strategy, and 23% 
were OLIG2+, but none were NG2+, PDGFRA+, or NKX2-2+, consistent with OPC depletion 
(Figure 3C). In contrast, by DIV7, the percentage of EGFR+ cells had decreased to 40-48%, 
while the percentage of OLIG2+, PDGFRA+, NG2+ and NKX2-2+ cells had increased to 35%, 
35%, 36% and 28%, respectively (Figure 3C). Reduction of EGFR-expressing progenitor cells 
accompanied the generation of OPCs, suggesting that EGFR+ progenitors in the germinal 
zone of the cortex have the ability to produce OPCs. 
 
We reasoned that if the EGFR-expressing cells were progenitors of OPCs, then manipulation 
of the EGFR signaling pathway might affect EGFR-expressing cell proliferation and ultimately 
change OPC production. To test this possibility, we cultured human brain slices at GW20-24, 
and treated adjacent slices with EGF, or with the EGFR inhibitors, Iressa, AG1478, or 
PD153035. Slices were incubated with BrdU for 12h before fixation at DIV7. In comparison 
with DMSO treated control slices, the number of both OLIG2+KI67+ and NKX2-2+BrdU+ cells 
increased by EGF treatment in a dose dependent manner, while both populations decreased 
dramatically when treated by all three of the EGFR inhibitors (Figure 3D). The decrease in 
OPC proliferation in the presence of EGFR inhibitors demonstrates that EGF endogenously 
activates OPC production in cortical slices. This result combined with the differentiation assay 
supports the concept of local generation of OPCs from EGFR-expressing progenitors in late 
second trimester human cortex. 
 
oRGs as an Additional Source Generate OPCs in the Developing Human Brain  
When we characterized OPCs in fixed human cortical sections by immunohistochemistry, we 
noticed that at GW20-24 the VZ did not contain many PDGFRA+OLIG2+ cells compared with 
other laminar regions (Figure S1). In contrast, the highest density of OPCs was found in the 
OSVZ, suggesting substantial OPC production in this region. During evolution, an increase in 
the diversity and number of progenitor cells within an enlarged OSVZ is thought to contribute 
to cortical expansion (Rakic 2009; Lui et al., 2011; Taverna et al., 2014; Fernandez et al., 
2016). Our in vivo immunohistochemistry data outlined above show that both 
PDGFRA+OLIG2+KI67+ OPCs and EGFR+OLIG2+KI67+ Pre-OPCs were mainly located in the 
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OSVZ (Figure S1 and S3), suggesting a local source of OPC production in the OSVZ. 
Neurogenic oRGs are a subtype of radial glia found in the primate OSVZ that are rare in 
rodents and are thought to contribute to developmental and evolutionary grey matter 
expansion (Hansen et al., 2010; Fietz et al., 2010). However, the mechanisms underlying white 
matter expansion remain unknown, and whether oRGs are involved in human gliogenesis has 
not been fully demonstrated. Here, through differential gene expression analysis based on 
scRNA-seq data of human OPCs, we found that the Pre-OPC cluster (cluster 14) identified 
above also expressed the oRG genes PTPRZ1, TNC, MOXD1, HOPX, and FAM107A (Pollen 
et al., 2015) (Figure 2B), suggesting that oRGs might generate OPCs in the developing human 
cortex. 
 
To validate the presence of a population of oRG marker-expressing OPCs in the human brain, 
we performed immunohistochemistry of fixed cortical sections between GW20 and GW24. We 
found that fewer than 2% of PDGFRA+OLIG2+ cells co-expressed the oRG markers, HOPX, 
PTPRZ1, TNC, and pS6 (Figure S4A). Moreover, these oRG marker-expressing OPCs 
exhibited immature bipolar morphology, and were mainly located in the ISVZ and OSVZ in the 
late second trimester. However, these cells were far less numerous than contemporaneous 
EGFR+PDGFRA+OLIG2+ cells (Figure 3A and Figure S2). Given that we characterized EGFR-
expressing cells as intermediate progenitors for OPCs, we think that oRGs might generate 
OPCs indirectly through oligodendrogenic IPCs (Pre-OPCs). Thus, we co-stained EGFR-
expressing cells with oRG markers. We already showed that most EGFR+OLIG2+ cells did not 
express the active mTOR readout and oRG marker pS6, and most TNC+Sox2+ oRGs did not 
express EGFR either (Figure 3B), but we found that about 10% of PTPRZ1+SOX2+ oRGs in 
the OSVZ expressed EGFR, and nearly 20% of EGFR+OLIG2+ progenitors were co-labeled 
with the oRG marker HOPX (Figure S4B). This indicated that the expression time windows of 
different oRG markers might be slightly different from one another, and that some of oRG 
progeny still retain oRG marker expression, enabling lineage tracing and trajectory 
reconstruction. Distribution analysis of fixed cortical sections at GW22 revealed that the 
HOPX+EGFR+OLIG2+ cells were mainly located in the OSVZ (Figure S5), consistent with the 
possibility that they represent a transitional stage from oRG to Pre-OPC. This would suggest 
that oRGs might be the precursors of EGFR-expressing intermediate progenitors that produce 
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OPCs. This concept is supported by our lineage trajectory reconstruction in which HOPX+TNC+ 
oRGs were positioned at the beginning of the pseudo-lineage tree. The lineage continued with 
VIM+EGFR+ progenitors that further branched into EOMES+ neurogenic IPCs or OLIG2+ Pre-
OPCs (Figure 2D and 2E). 
 
We further sought to directly test whether HOPX-expressing oRGs could generate OPCs. Cells 
were dissociated from the micro-dissected OSVZ at GW20 to GW24. Two sequential rounds of 
negative selection of (PDGFRA+O4)- and EGFR-immunopanning were performed in order to 
deplete both OPCs and Pre-OPCs in the cell suspension, and oRGs were further enriched 
through positive selection by LIFR-immunopanning as LIFR has been previously described as 
a marker of oRGs (Pollen et al., 2015). The LIFR-expressing progenitors were cultured in LIF 
containing medium for two days and then in EGF and PDGF containing medium for another 
eight days, and fixed at DIV2 and DIV10, respectively (Figure S4C). At DIV2, around 90% of 
the cells expressed SOX2, and more than 90% of the SOX2+ cells were GFAP+HOPX+, 
indicating oRG identity. None were PDGFRA+, OLIG2+ or EGFR+, consistent with OPC and 
Pre-OPC depletion (Figure S4C). In contrast, at DIV10, the percentage of SOX2+ cells 
decreased to 82%, and the percentage of GFAP+HOPX+ cells decreased to 50%. Meanwhile, 
the percentage of EGFR+ cells increased to 44%, and the percentage of PDGFRA+OLIG2+ 
cells increased to 17% (Figure S4C). Reduction of GFAP+HOPX+SOX2+ oRGs accompanied 
the generation of PDGFRA+OLIG2+ OPCs, suggesting LIFR-antibody enriched oRGs are able 
to produce OPCs. The observation that nearly all the PDGFRA+OLIG2+ OPCs generated at 
DIV10 also expressed EGFR indicates that oRGs generate OPCs through EGFR-expressing 
Pre-OPCs, consistent with the lineage reconstruction based on scRNA-seq analysis (Figure 
2D and 2E). This differentiation assay combined with scRNA-seq and in vivo 
immunohistochemistry data indicate that a population of oRGs at the late second trimester act 
as neural progenitor cells for oligodendrogenesis. Our results also suggest that besides 
ventricular radial glia (vRG) present in both rodent and primate brain, the large abundance of 
oRGs in the developing human brain provides an extra source of OPC production absent in 
rodents, that could enhance oligodendrocyte generation and boost myelination to match 
demands arising from increased neurogenesis in the human brain.  
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Unique Division Dynamics of EGFR-expressing Progenitors in the OSVZ 
Since EGFR-expressing cells appear to be intermediate progenitors that bridge oRGs and 
OPCs, we sought to study the proliferative behavior of these cells and compare them with the 
distinct mitotic behavior of oRGs and OPCs by time-lapse imaging. Due to the diversity of 
progenitors in the germinal zones at late second trimester and the lack of genetic tools to 
specifically label OPCs, EGFR-expressing IPCs, or oRGs, we dissociated cortical cells from 
OSVZ at GW20 to GW24 and performed immunopanning to selectively enrich specific 
progenitor populations through positive selection with PDGFRA-, EGFR-, and LIFR-antibody 
sequentially (Figure 4A). We subsequently labeled the individual enriched progenitor types by 
infecting them with CMV-GFP adeno-virus and transplanted the virus-labeled progenitors into 
the OSVZ of brain slices from the same tissue samples where the cells were derived. We then 
cultured the brain slices without adding any growth factors (Figure 4B). Since cultured slices 
largely preserve tissue integrity for at least one week in culture, including cortical layer 
structure (Noctor et al., 2001; Hansen et al., 2010), we reasoned that this experimental system 
could preserve many features of the in vivo niche supporting progenitor development. 
 
To validate the identity of enriched cells, we performed 10X scRNA-seq of the immunopanned 
cells prior to virus infection and transplantation. Featured gene plots indicated a high efficiency 
of immunopanning. Most LIFR-panned cells highly expressed LIFR, and the major clusters 
were also enriched for GFAP, PAX6, HOPX and PTPRZ1, indicating oRG identity, while the 
remaining non-oRG clusters were astrocytes, LIFR-expressing microglia, or newborn neurons 
according to their mRNA profiles (Figure S6A and S6B). Similarly, most EGFR-panned cells 
expressed EGFR, and these clusters were also enriched for NES, SOX2 and VIM, consistent 
with the immunostaining in the fixed brain slices and indicating progenitor identity (Figure S4B, 
S6A and S6B). Most PDGFRA-panned cells expressed PDGFRA, and the major clusters were 
also enriched for OLIG1, OLIG2, NKX2-2 and SOX10, indicating OPC identity, while the 
remaining non-OPC clusters were mainly microglia according to their mRNA profiles (Figure 
S6A and S6B).  
 
Video frames were captured every 35 minutes over a three-day time window from DIV3 to 
DIV6, and GFP-labeled progenitors on cultured brain slices were observed to migrate and 
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divide. Interestingly, most LIFR-panned cells acquired a long radial fiber after transplantation, 
characteristic of radial glia (Figure S6C). The remaining non-radial cells might represent off-
target cells or progeny generated by oRGs during the three days required for cell recovery and 
virus expression. Both EGFR- and PDGFRA-panned cells exhibited bipolar morphology but did 
not show any orientation preference (Figure S6C). As expected, the radial cells enriched by 
LIFR-panning underwent mitotic somal translocation (MST) (Figure 4C and Movie S1), a 
unique “jump and divide” behavior of oRGs that is not observed in vRGs, neuroepithelial cells, 
or other known cortical progenitors (Hansen et al., 2010; Noctor et al., 2001; Betizeau et al., 
2013; Subramanian et al., 2017). In contrast, PDGFRA-panned cells rounded up in place to 
divide (Figure 4C). Most EGFR-panned cells also jumped and divided as oRGs did, but the 
distance of MST was much smaller (Figure 4C and Movie S2). Both daughter cells regrew 
processes, thereby resembling OPC behavior (Figure 4C). After division, daughter cells of both 
oRGs and EGFR-panned cells stayed close to each other, while the daughter cells of OPCs 
rapidly migrated away from each other. Figure 4D and 4E show the quantification of MST 
distance and daughter cell distance from 30 samples of each type of cell. Both time stamped 
still images and statistic results indicate that EGFR-expressing cells exhibit their own unique 
proliferation pattern, but with features resembling a combination of oRG and OPC behavior, 
consistent with an identity as an intermediate progenitor between oRGs and OPCs. Lineage 
reconstruction by monocle based on scRNA-seq data of unbiased captured cells (Bhaduri et 
al., 2020) also supports the developmental trajectory from oRGs to EGFR-expressing IPCs to 
OPCs (Figure S6D). 
 
We next incubated brain slices with either EGF or EGFR inhibitor Iressa after EGFR-panning, 
virus labeling, and cell transplantation. When post-stained for NKX2-2 and GFP at DIV7 and 
compared with DSMO treated control slices, EGF treatment increased while Iressa treatment 
decreased OPC production from EGFR-panned cells (Figure 4E), indicating an essential role 
of EGFR-expressing cells in OPC generation. 
  
Transient Amplification of Human OPCs in the Late Second Trimester 
We next focused on the proliferative ability of OPCs by studying the time-lapse image data 
generated above. An average of 20 cells were found to divide within a single visual field, and 
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42 cells were observed to undergo two rounds of division in the total of twenty-four visual 
fields. Figure 5A shows an example of an OPC that divided to generate two daughter cells, 
both of which divided again at similar time points to produce four granddaughter cells (Movie 
S3). These observations suggest that OPCs undergo frequent repeated symmetric divisions to 
exponentially increase the progenitor cell pool. This differs from observations of the mouse 
brain at comparable neonatal ages, where NG2-expressing OPCs divide only once in a five-
day period to generate two daughter cells that continue to express NG2 for several days 
before one or both differentiate into oligodendrocytes (Zhu et al, 2011; Hill et al., 2014). 
 
Since OPCs migrate actively in our time-lapse recordings, daughter cells often migrate out of 
the field of vision, making it difficult to quantitatively analyze the percentage of continuously 
dividing OPCs by live imaging. Thus, we performed thymidine analog labeling to quantify cell 
divisions (Figure 5B). OPCs were enriched by PDGFRA-immunopanning and labeled with 
CMV-GFP adeno-virus prior to transplantation into cultured brain slices. Our time-lapse 
imaging indicated that the time interval between two rounds of division was about 36h. 
Considering that thymidine is incorporated into cells at S-phase, and G1-phase is usually the 
longest phase of the cell cycle, we incubated the brain slices with the thymidine analog, 
chlorodeoxyuridine (CldU), for 12h followed by 24h without thymidine analog, and then another 
12h exposure to the thymidine analog, iododeoxyuridine (IdU), followed by 24h without 
thymidine analog prior to fixation. This was intended to differentially label successive rounds of 
cell division and to avoid CldU and IdU incorporation into cells during the same S-phase. Three 
rounds of washing with DPBS after CldU and IdU incubation ensured removal of 
unincorporated thymidine analog. After fixation we stained the brain slices with OLIG2-
antibody to confirm the oligodendrocyte lineage identity of the GFP-virus labeled PDGFRA-
immunopanned cells (Figure 5B). Quantitative analysis showed that nearly 95% of GFP cells 
were OLIG2+, indicating a high efficiency of OPC enrichment. Figure 5B is a high magnification 
image showing an example of a GFP labeled PDGFRA-immunopanned cell that expresses 
OLIG2 and is co-labeled with both CldU and IdU. Approximately 35% of GFP+OLIG2+ cells 
were either CldU or IdU positive, while 8% of GFP+OLIG2+ cells were both CldU and IdU 
positive, indicating two rounds of cell division after OPC commitment (Figure 5B). Considering 
that cells were exposed to the thymidine analog for only one third of their cycle, and that the 
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cycling OPCs were unsynchronized, the proportion of cycling cells should be triple the 
thymidine analog-labeled number. 
 
Both time-lapse imaging and thymidine analog labeling suggest continuous division of OPCs in 
the developing human brain. This is consistent with our findings based on staining of fixed 
brain sections indicating that both bipolar early-OPCs and multipolar late-OPCs are KI67+. 
These results support the concept that during human cortical development, OPCs undergo a 
prolonged period of proliferation before differentiation and thus act as transit amplifying cells to 
greatly increase the progenitor pool through symmetric division. Presumably, the significant 
increase in OPCs at this stage helps produce the large number of oligodendrocytes needed to 
myelinate the expanded human cortex. 
 
OPC-enriched PCDH15 Mediates Daughter Cell Separation and Dispersal after Division 
Previous studies and our above time-lapse imaging of LIFR- and EGFR-panned cells have 
shown that the daughter cells of progenitors usually stay in contact or close to each other long 
after division (Hansen et al., 2010; Betizeau et al., 2013; Subramanian et al., 2017). However, 
our time-lapse imaging of PDGFRA-panned cells revealed an unusual behavior of OPC 
daughter cells following division that differed from the post-mitotic behavior of other progenitors 
such as RGs and IPCs. Immediately following OPC division, the newly generated daughter 
cells appeared to repel each other and migrated rapidly in opposite directions (Figure 6C). We 
reasoned that this behavior might serve to ensure broad distribution of OPCs across the 
developing cortex.  
 
To explore the mechanism underlying repulsion, we first compared the RNA profiles of dividing 
OPCs with other dividing cortical progenitors, whose daughters do not repel each other after 
division (RGs and IPCs). The list of differentially expressed genes included the cell surface 
molecules PCDH15 and DSCAM, which ranked high among OPC-enriched genes (Figure 7A 
and 7B). DSCAM belongs to the immunoglobulin superfamily of cell adhesion molecules. It 
promotes repulsion between neurites and mediates tiling between neurons (Fuerst et al., 2008; 
Hattori et al., 2008). PCDH15 is a member of the protocadherin superfamily. Although the 
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function of PCDH15 in OPC development is unknown, other members of the protocadherin 
family have been reported to mediate dendritic self-avoidance (Lyfebvre et al., 2012). 
 
In order to study the function of PCDH15 and DSCAM in OPCs, we sought to knockdown 
PCDH15 or DSCAM by shRNA lentivirus. Four shRNA hairpins for PCDH15 (PCDH15-shRNA-
A/B/C/D) and DSCAM (DSCAM-shRNA-A/B/C/D), respectively, were designed and two each 
were found to down-regulate either PCDH15 (PCDH15-shR-C/D) or DSCAM (DSCAM-shRNA-
A/B) at both mRNA and protein levels in HEK293T and OPCs (Figure S7A and S7B). We 
performed PDGFRA-immunopanning to enrich human OPCs at GW20-24 and infected them 
with either PCDH15-shRNA-GFP or DSCAM-shRNA-GFP lenti-virus. After three hours of virus 
incubation we transplanted the virus infected OPCs into cultured cortical slices and performed 
time-lapse imaging three days later. The scramble-control exhibited similar behavior to that 
observed in the CMV-GFP adeno-virus labeled cells (Figure 5A and Movie S3), namely OPC 
daughter cells repelled each other and migrated rapidly in opposite directions (Figure 6C and 
Movie S4). In contrast, the PCDH15-shRNA infected daughter cells remained in contact with or 
close to each other following division, often for many hours (Figure 6C and Movie S5). 
Quantitative analysis of daughter cell distance from one another showed dramatic increase 
from 5 to 10 to 15 hours after OPC division in the scramble control, while the separation 
between daughter cells was much smaller in both PCDH15-shRNA-C and -D at the same time 
point, with no obvious increase between different time points (Figure 6D), indicating significant 
inhibition of daughter cell dispersion after PCDH15 knockdown. Statistical analysis of the 
migration speed before division shows no obvious difference between scramble-control and 
PCDH15-shRNA (Figure 6E), indicating that the inhibition of OPC dispersion is not due to an 
underlying mobility defect. The DSCAM-shRNA infected OPCs repelled each other similarly to 
control, indicating DSCAM is dispensable for daughter cell repulsion.  
 
To confirm that PCDH15 plays a key role in OPC daughter cell repulsion, we blocked PCDH15 
function by antibody incubation instead of shRNA mediated gene knockdown. Again, OPCs 
were enriched by PDGFRA-immunopanning and labeled with CMV-GFP adeno-virus. Two 
days after cell transplantation we applied PCDH15-antibody to the cultured brain slices and 
performed live imaging. Since PCDH15 is a membrane-tethered protein, the PCDH15-antibody 
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that we chose binds to the extracellular domain and would be expected to block protein 
function. FACS of live HEK293T cells overexpressing protocadherin indicated that PCDH15-
antibody had preferential affinity to PCDH15- but not other protocadherin family members 
(Figure S7C). Adjacent brain slices injected with GFP labeled OPCs and exposed to the same 
concentration of IgG derived from the corresponding animal species served as a control. OPC 
behavior was normal in the control slices (Figure S7D and Movie S6), while a similar 
abnormality as in the PCDH15-shRNA was observed in the PCDH15-antibody treated brain 
slices; newly generated OPC sister cells stayed together long after cell division (Figure S7D 
and Movie S7). Thus, both shRNA knockdown and antibody blocking indicated that PCDH15 is 
required for daughter cell separation after OPC division, a behavior that might be important for 
evenly distributing OPCs across the cortex. 
 
Homeostatic Control of OPC Density by PCDH15 
As self-avoidance is often closely related to tilling (Hattori et al., 2008), we wondered whether 
PCDH15 plays a role in OPC tiling, a phenomenon that distributes OPCs in a non-redundant 
manner to maximize coverage of the surface while minimizing overlap between neighboring 
OPCs (Hughes et al., 2013). Cultured human cortical slices were incubated with PCDH15 
antibody and fixed at DIV7. Staining with O4 and OLIG2 were performed to show the 
processes and nuclei of the OPCs. In comparison with IgG-control, PCDH15-antibody treated 
slices showed no significant differences in either process arborization or soma distribution 
(Figure 7A), indicating PCDH15 may not be involved in OPC tiling. Furthermore, when we 
analyzed the time-lapse imaging data of PDGFRA-panned cells, we observed no obvious 
repulsion between two random OPCs when they encounter each other (Movie S8), indicating 
PCDH15-mediated repulsion might only occur between daughter cells when they separate 
right after division. 
 
We noticed that many PCDH15-shRNA daughter cells did not re-enter the cell cycle, even long 
after dividing (>40hr), while the Scramble-control OPCs usually underwent two rounds of 
division during this same interval. Figure 7B shows one PCDH15-shRNA infected OPC sample 
that divided to generate two daughter cells close to each other. Instead of both daughter cells 
dividing to generate four granddaughter cells at a second round of division (Figure 5A), only 
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one daughter cell divided to generate two granddaughter cells close to each other, while the 
other daughter cell remained quiescent (Movie S9). This suggests that failure of dispersion of 
daughter cells might inhibit further division, potentially helping to achieve homeostatic control 
of local OPC density. We sought to quantify whether knockdown of PCDH15 affects OPC 
proliferation. We fixed cultured human cortical slices treated with PCDH15-antibody at DIV7 
and post-stained them with NKX2-2 and KI67. There was no significant difference in the 
density of NKX2-2+ cells between IgG-control and PCDH15-antibody blocking, while both the 
number and percentage of NKX2-2+KI67+ cells were decreased dramatically after incubation 
with PCDH15-antibody compared with IgG-control. Both time-lapse imaging and antibody 
blocking experiments support the idea that PCDH15-mediated daughter cell separation and 
dispersion prevent local OPC accumulation and facilitate OPC proliferation. 
 
DISCUSSION 
Due to restricted access to human tissue samples and a limited capacity for experimental 
manipulation, most of our knowledge about gliogenesis has been obtained from studies in 
animal models, primarily rodents, while relatively little is known about human 
oligodendrogenesis. During evolution, the human neocortex enlarged dramatically with 
considerable expansion of not only grey matter, but also white matter. The evolutionary 
expansion of grey matter has been attributed to a prolonged gestational period as well as the 
presence of novel neural stem cell populations and intermediate progenitor cells that greatly 
increase the neuronal output of cortical germinal niches. However, little is known about the 
mechanisms underlying white matter expansion and how oligodendrocyte production is 
regulated to meet the increased demands for myelination. Developmental features of 
oligodendrocyte precursor cells observed in animal models might not apply to human brain 
development, particularly given the large structural and volume differences between human 
and rodent cortex. By combining scRNA-seq analysis, in vivo immunohistochemistry, ex vivo 
brain slice culture, and time-lapse imaging, we map the lineage trajectory of 
oligodendrogenesis in the developing human cortex and identify a novel type of intermediate 
progenitor cells (EGFR-expressing Pre-OPCs) in the OSVZ that generate OPCs. We also 
discover that oRG cells are an additional source of cortical OPCs in the developing human 
brain that has not been observed in rodents, and uncover an enhanced proliferative ability of 
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embryonic OPCs that helps to produce the large number of oligodendrocytes associated with 
human cortical expansion. We further demonstrate repulsive behavior between OPC daughter 
cells, mediated by an OPC-specific protocadherin family member, PCDH15, which promotes 
dispersal of OPCs and facilitates OPC proliferation. These findings extend our comprehension 
of human cortical expansion and human oligodendrogenesis. 
 
The Role of oRGs in Human Cortical Oligodendrogenesis 
During peak periods of neurogenesis in human cortical development (GW13-19), oRGs 
populate the OSVZ and produce EOMES-expressing transit-amplifying IPCs that ultimately 
generate neurons. The abundance of oRGs in primates contributes to the production of large 
numbers of neurons and provides a secondary radial glia scaffold to support neuronal 
migration (Lui et al., 2011; Taverna et al., 2014; Fernandez et al., 2016; Gertz, et al., 2015). 
However, direct evidence for a possible role of oRGs in gliogenesis is lacking (Rowitch and 
Kriegstein, 2010). A recent study of the developing macaque suggested that oRGs support 
oligodendrogenesis, but lacked functional validation, highlighting the need for experimental 
studies to determine the identity and role of oligodendrocyte progenitors in the developing 
primate brain (Rash et al., 2019). Here, by combining scRNA-seq analysis with 
immunohistochemistry and primary cell culture, we find evidence for oRG-derived OPC 
generation in the cerebral cortex. Our study highlights the important role of oRGs for both 
neurogenesis and gliogenesis. It will be interesting to further compare early neurogenic oRGs 
with late oligodendrogenic oRGs, and study the mechanisms underlying the temporal switch 
from neurogenesis to oligodendrogenesis. 
 
EGFR-expressing Intermediate Progenitors and Oligodendrogenesis 
EGFR is widely recognized for its importance in cancer, where excessive activation of EGFR 
signaling often leads to hyper-proliferation of tumor cells (da Cunha Santos et al., 2011; 
Eskilsson et al., 2018). Here, at the onset of gliogenesis, we find that large numbers of EGFR 
expressing progenitors occupy germinal zones of the embryonic human cortex and support 
OPC production. Both lineage reconstruction and differentiation assays indicate that oRGs do 
not generate OPCs directly, instead EGFR-expressing cells act as intermediate progenitors for 
oligodendrogenesis. The existence of proliferative Pre-OPCs lying between the oRGs and 
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OPCs in the lineage trajectory may serve to increase the rounds of division and enlarge the 
progenitor pool. The responsiveness of Pre-OPCs to EGF suggests a tight regulation of OPC 
production by EGF secreted in the progenitor cell niche of the developing cortex. Interestingly, 
we find that a subset of oRGs express EGF mRNA in our scRNA-seq database. This suggests 
a possible mechanism for coordination between neurogenesis and oligodendrogenesis, which 
could serve to match the increase in neuron production to the requirement of more 
oligodendrocytes for axon myelination. Alternatively, it might represent a positive feed forward 
mechanism to facilitate OPC production. 
 
Pre-OPCs in Mouse and Human Brain 
Co-expression of NPC genes with early OPC markers has helped to illuminate OPC origins. A 
form of Pre-OPCs has been identified in the mouse forebrain by scRNA-seq of PDGFRA-GFP+ 
cells (Marques et al., 2018). The Pre-OPCs, present at E13.5 but nearly absent at E17.5, 
express markers of both NPCs and OPCs and represent a transitional stage from NPCs to 
OPCs. Bulk tissue sequencing indicates that transcription factors involved in ganglionic 
eminence patterning (Otx2, Nkx2-1, and Arx) are highly expressed in these mouse Pre-OPCs 
(Marques et al., 2018), consistent with the concept that ventral-derived NPCs are the main 
source of mouse forebrain OPCs at early embryonic stages (Kessaris et al., 2006). Similarly, 
scRNA-seq of cells from the ventral midbrain of E13.5 mouse and PCW 10-11 (GW8-13) 
human have identified radial glia-like cell types that express OPC markers, representing a 
transitional stage from basal plate radial glia to OPCs (La Manno, et al. 2016). In contrast, our 
Pre-OPCs are identified at much later ages during GW20-24 and have not been described in 
mice at comparable ages (postnatal days) (Marques et al., 2018). They co-express some of 
oRG markers, exhibit hybrid MST behavior and are mainly located in the OSVZ, indicating a 
prolonged period of NPC to OPC transition in the developing human cortex and a source of 
oRG-derived OPCs absent in mouse. Our findings combined with mouse and early stage 
human data summarized above support the notion that diverse NPCs and Pre-OPCs converge 
into similar transcriptional OPC states (Marques et al., 2018). 
 
Progenitor Diversity in the OSVZ 
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During evolution, primates developed an enlarged cortical germinal zone, the OSVZ, which is 
lacking in most rodents. Previous studies have highlighted the critical role of the OSVZ as a 
site for neuron production in large-brain mammals (Hansen et al., 2010; Fietz et al., 2010; 
Betizeau et al., 2013; Nonako-Kinoshita et al., 2013). Here we find large numbers of dividing 
progenitor cells that support OPC production, including oRGs, Pre-OPCs, and OPCs, in the 
human OSVZ and neighboring IZ at the onset of gliogenesis. The OSVZ and IZ together span 
more than half of the total cortical thickness at the end of the second trimester. Such a 
relatively large area, populated by a high density of KI67+ progenitors, facilitates production of 
large numbers of neurons and glia. At stages of peak neurogenesis (GW13-19) the OSVZ 
contains two major types of progenitors, oRGs and neurogenic IPCs, while at later stages the 
progenitor cell types of the OSVZ appear to be more diverse. At GW20-24, we identify at least 
four types of progenitors in the OSVZ, including GFAP+pS6+SOX2+ oRGs, EOMES+SOX2- 
IPCs, EGFR+SOX2+OLIG2+ Pre-OPCs, and EGFR-PDGFRA+OLIG2+ OPCs. Considering that 
astrocyte production also occurs at this stage, and that both oligodendrogenesis and 
astrogenesis continue through the third trimester, the progenitor cell types are likely to be even 
more diverse than outlined above. It will be interesting to study progenitor cell diversity at these 
later stages and learn how progenitors may interact to coordinate neurogenesis and 
gliogenesis. 
 
Symmetric Division and Transit Amplification 
OPCs maintain the ability to self-renew and continuously generate oligodendrocytes 
throughout life (Kang et al., 2010; Young et al., 2013). But unlike embryonic OPCs, most OPCs 
in the adult brain are quiescent under normal conditions (Yeung et al., 2014). Here we observe 
that OPCs in the developing human cortex act as transit amplifying cells, continuously 
proliferating through symmetric division to exponentially increase the oligodendrocyte 
progenitor pool. As a result, in a prolonged period spanning at least five weeks (GW20-24), 
large quantities of OPCs can be generated, producing oligodendrocytes sufficient to populate 
the large area of expanded white matter. Interestingly, nearly all PDGFRA+OLIG2+ OPCs at 
this stage are SOX2+, consistent with previous reports that SOX2 maintains OPCs in a 
proliferative state and inhibits differentiation (Zhao et al., 2015). OPCs may also serve as a cell 
of origin for glioblastoma (Persson et al., 2010; Liu et al., 2011; Zong et al., 2015; Weng et al., 
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2019). Considering that OPC-like tumor cells are hyper-proliferative, they may be closer to 
embryonic human OPCs than more mature adult OPCs. Here we provide gene signatures for 
embryonic human OPCs, and comparisons of the mRNA-profiles of adult human OPCs, 
embryonic human OPCs, and OPC-like tumor cells may provide an opportunity to discover key 
molecules that may be essential for hyper-proliferation and could serve as candidate targets 
for tumor therapy. 
 
Cell Repulsion and Homeostatic Control of OPC Density 
In the adult mouse brain, OPCs occupy mutually exclusive territories through a balance 
between proliferation and self-repulsion, although the molecular mechanisms are unknown 
(Hughes et al., 2013). In the embryonic human cortex, we observe a self-avoidance behavior 
between daughter cells following OPC division. This behavior is very unique compared with the 
phenotype observed in other dividing cells of the developing cortex, including RGs or IPCs, 
where daughter cells stay in contact long after division (Noctor et al., 2001; Hansen et al., 
2010; Betizeau et al., 2013). This is particularly notable when RGs divide asymmetrically to 
self-renew and generate a neuron, which remains in contact with the parent RG fiber as it 
migrates. Consecutive divisions of individual RGs and their IPC daughter cells produce a clone 
of sister cells that remain in contact and eventually form a columnar array of clustered 
neocortical neurons (Noctor et al., 2001; Yu et al., 2009). In contrast, when OPCs in our study 
divide symmetrically, the two daughter OPCs strongly repel each other and migrate in opposite 
directions. This behavior likely serves to avoid local accumulation and ensure broad 
distribution of OPCs. We find that the mechanism of repulsion involves the protocadherin 
superfamily member PCDH15 that is selectively enriched in OPCs. According to our differential 
expression data, DSCAM is also enriched in OPCs, but our functional assays indicate it is not 
involved in daughter cell repulsion, highlighting the specificity of PCDH15 for OPC dispersion. 
Furthermore, we observe that failure of daughter cell separation impairs the ability of daughter 
cells to engage in subsequent divisions, reflecting a cellular mechanism underlying 
homeostatic control of OPC density during development and highlighting the importance OPC 
dispersion on OPC proliferation and white matter expansion. 
 
Unique Gene Expression Profile of OPCs 
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PCDH15 is not only a gene differentially expressed between dividing OPCs and RGs or IPCs, 
but also serves as a marker gene for OPCs. Because our database was composed of most 
cell types present in the developing human cerebral cortex, including RGs, IPCs, neurons, 
astrocytes, and microglia, our gene expression database afforded an opportunity to discover 
new marker genes for OPCs. Differential gene expression analysis highlighted several 
additional cell type-specific candidate genes, such as LHFPL3, B3GNT7, LUZP2, and SCN1A 
(Figure S8A). Future work elucidating the function of these genes in OPC biology may provide 
insight into human oligodendrocyte development. 
 
OPCs and Cerebral Cortical Malformation 
High throughput sequencing has uncovered a number of gene mutations related to cortical 
malformations including microcephaly, lissencephaly, and polymicrogyria (Walsh, 1999; Hu et 
al., 2014). Although a majority of the gene mutations in patients are germ line mutations, most 
studies of the molecular and cellular mechanisms have focused on the neuronal lineage, while 
abnormalities in glia have generally not been considered. Our scRNA-seq dataset shows that 
many genes related to brain malformation are also enriched in OPCs. For example, the 
microcephaly related genes ASPM, STIL, CEP135, CDK6, RBBP8, CEP152 and CENPJ are 
all highly expressed in neuronal progenitors including dividing RGs and IPCs, but they are also 
highly expressed in dividing OPCs (Figure S8B), suggesting that disease-causing mutations in 
these genes might also directly interfere with the production of oligodendrocytes, and thus 
contribute to microcephaly. Additionally, our dataset indicates that many polymicrogyria related 
genes are expressed broadly in both neural progenitors and OPCs, and many of the genes, 
such as GPR56, ATP6V0A2, GPSM2, NDE1, RAB18, CCND2, PTEN, DYNC1H1, KIF5C, 
TUBA1A, TUBB2A, TUBB2B, BICD2, DDX3X, EZH2 and OFD1, show equal or even higher 
expression levels in OPCs compared with other cell types (Figure S8C). This strongly suggests 
that an abnormality in OPCs might contribute to polymicrogyria. Together, these cell-type 
selective gene expression patterns can inform future analysis of genetic variants associated 




We thank Hiroko Nobuta, Manideep Chavali, and Shawn Sorrells for providing resources, 
suggestions and technical assistance. Donated tissue samples were obtained in strict 
compliance with institutional guidelines and ethical oversight. This research was supported by 




A.R.K., W.H., A.A.B., and D.H.R. conceived and supervised the project. W.H. designed and 
performed all the functional experiments. A.B. and D.V. performed bioinformatics analysis. 
S.W. collected tissue samples and made the frozen sections for immunohistochemistry. L.W. 
performed shRNA efficiency test and FACS based antibody specificity test. C.A.R. initiated this 
project. W.H., A.R.K., and D.H.R. wrote the manuscript with the input from all authors. 
 
DECLARATION OF INTERESTS 







Figure 1. Single-cell RNA-sequencing of OPCs from the Developing Human Cortex. 
(A) Schematic of the workflow. Developing human cortex was dissociated and OPCs enriched 
by PDGFRA-immunopanning. Single-cells were isolated using the Fluidigim C1 microfluidic 
chip system, and pair-end single-cell RNA-sequencing performed. Clustering was used to 
annotate cell types according to RNA profiles. 
(B) Scatterplot by tSNE (left) and feature plot of PDGFRA-mRNA expression (right) from 
Nowakowski et al., 2017. Single-cell RNA-sequencing performed on forty-eight individuals 
mainly at GW14-24 from primary dissociated cortex without enrichment resulted in capture of 
few OPCs (PDGFRA-expressing). 
(C) Validation of the immunopanning strategy. Most DAPI-stained cells were PDGFRA+NKX2-
2+, while more than 90% of sequenced cells expressed PDGFRA mRNA, indicating high 
efficiency OPC enrichment. 
(D) Scatterplot by tSNE (left) and feature plot of PDGFRA-mRNA expression (right) of data 
generated in this study from nine individuals at GW20-24 combined with Nowakowski et al., 
2017. A total of 980 OPCs were identified and intermixed with those captured without 
enrichment (B). 
(E) Heatmap showing cluster annotations and marker gene expression. 
(F) Feature plots of marker genes. OPCs are segregated from neural progenitor cells (NPC) 







Figure 2. Characterization of OPC Clusters from Single-cell RNA-sequencing. 
(A) Enlarged tSNE plot from Figure 1D focusing on the OPC clusters. Clusters are shown on 
the left, and metadata annotation of tissue source is represented on the right. 
(B) Violin plots of differentially expressed genes in OPC clusters. Marker genes for NPCs and 
oRGs are enriched in cluster 14 and cell cycling genes are enriched in cluster 11. Pan-OPC 
marker genes are expressed in all OPC clusters, but are relatively low in cluster 14. 
(C) Similarity matrix of OPC, NPC, and neuronal clusters. OPCs are segregated, but cluster 14 
resembles NPC. 
(D) Trajectory analysis of progenitor and OPC cell types using Monocle. Broad cell types are 
shown rather than individual clusters. 
(E) Feature plots of marker genes for NPCs, IPCs, neurons and OPCs indicating lineage 





Figure 3.  EGFR-positive Progenitors Generate OPCs in the Developing Human Cortex. 
(A) Characterization of Pre-OPCs that co-express NPC and OPC markers. Images are from 
human OSVZ at GW20-24 (n=12). 
(B) Characterization of EGFR-expressing progenitors by oRG or IPC marker co-staining. 
Images are from human OSVZ at GW20-24 (n=12). 
(C) Outline of immunopanning workflow (left). PDGFRA and O4 were used to deplete OPCs, 
and EGFR positive selection enriched for progenitors. Images of marker staining at DIV2 and 
DIV7 showing lineage progression (middle). Quantification of cell proportions (right). Mean±SD 
(n=5). (***, p<0.001; **, p<0.01; *, p<0.05; N.S., p>0.05.) 
(D) Quantification of dividing OPCs inn cultured human brain slices after pharmacologically 
activating [EGF(High) and EGF(Low)] or inhibiting (Iressa, AG1478, and PD153035) EGFR. 
Mean±SD (n=6).  







Figure 4.  Characterization of EGFR-expressing Progenitors in the Developing Human 
Cortex. 
(A) Outline of immunopanning workflow. Different types of progenitors in the OSVZ were 
positively selected with PDGFRA-, EGFR- and LIFR-antibody by sequential immunopanning. 
(B) Schematic of the experimental strategy. Progenitors were enriched by immunopanning, 
infected with GFP adeno-virus, injected into cultured cortical slices, and observed for time-
lapse imaging. 
(C) Time stamped still images of dividing progenitors enriched by LIFR-, EGFR-, or PDGFRA-
panning. Representative cells from cultured cortical slices at GW20-24 (n=30). 
(D) Quantification of MST distance during division and daughter cell separation of different 
progenitors at 6 hours after division. Mean±SD (n=30). (***, p<0.001; N.S., p>0.05.) 
(E) Quantification of OPCs from EGFR-panned cells in cultured human brain slices after 
pharmacologically activating (EGF) or inhibiting (Iressa) EGFR. Mean±SD (n=6). (***, 
p<0.001.) 






Figure 5. Characterization of Division Properties of Human Embryonic OPCs. 
(A) Time stamped still images of dividing OPCs. Two rounds of continuous division were 
observed and four granddaughter cells were generated. Representative cell from a cultured 
cortical slice at GW22 (n=20). 
(B) Workflow to explore OPC division quantitatively (top left). OPCs were enriched with 
PDGFRA-immunopanning, and infected with GFP adenovirus before transplantation and 
thymidine analog labeling. Representative images from cultured cortical slices at GW20-24 
show a GFP-positive immunopanned cell co-labeled with CldU and IdU, and expressing OLIG2 
(bottom left) (n=20). Quantification of the proportion of GFP+OLIG2+ cells that express either 
CldU or IdU or both. Mean±SD (right). (n=10) 





Figure 6. PCDH15 Mediates Daughter Cell Repulsion after OPC Division. 
(A) Volcano plots show differentially expressed genes between dividing OPCs and dividing 
RGs (left) or dividing IPCs (right). Two of the most highly differentially expressed genes are 
DSCAM and PCDH15. 
(B) Feature plots of DSCAM (left) shows expression in excitatory neurons and OPCs, while 
PCDH15 is specific to OPCs. 
(C) Time stamped still images of dividing OPCs treated with either scramble-shRNA control 
lentiviruses or PCDH15-shRNA lentiviruses to interfere with PCDH15 function. The control 
division resulted in repulsion between daughter cells. With PCDH15 interference, the daughter 
cells remained close to each other. Representative cells are from cultured cortical slices at 
GW20-24 (n=30). 
(D) Quantification of daughter cell distance after division. Mean±SD (n=30). (***, p<0.001.) 
(E) Quantification of migration speed before division. Mean±SD (n=30). (N.S., p>0.05.) 






Figure 7. Interfering with PCDH15 Function Affects OPC Proliferation. 
(A) Sample images of OPCs in the OSVZ of cultured brain slices treated with either IgG as 
control, or PCDH15-antibody to interfere with PCDH15 function. Blocking to PCDH15 function 
did not cause obvious change in OPC morphology (indicated by O4-staining) and distribution 
(indicated by OLIG2-staining). 
(B) Time stamped still images of dividing OPCs infected with PCDH15-shRNA lentiviruses. 
Two rounds of continuous division were observed, and only one of the daughter cells divided 
again. Representative cells are from cultured cortical slices at GW20-24 (n=6). 
(C) Quantification of OPC division in the OSVZ of cultured brain slices treated with either IgG 
as control or PCDH15-antibody to interfere with PCDH15 function. Blocking to PCDH15 
function inhibited OPC proliferation but did not change local OPC density. Mean±SD (n=6). 
(***, p<0.001; **, p<0.01; N.S., p>0.05.) 
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KEY RESOURCES TABLE 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies for Immunopanning 
Mouse monoclonal anti-PDGFRA BD Biosciences Cat.# 556001 
Mouse monoclonal anti-O4 Millipore Cat.# MAB345 
Rat monoclonal anti-EGFR Abcam Cat.# ab231 
Mouse monoclonal anti-LIFR Abcam Cat.# ab89792 
Donkey anti-Mouse IgG Jackson Immuno Cat.# 715-005-151 
Donkey anti-Mouse IgM Jackson Immuno Cat.# 715-005-020 
Goat anti-Rat IgG Jackson Immuno Cat.# 112-005-003 
Antibodies for Immunohistochemistry 
Rabbit anti-PDGFRA, 1:500 Cell Signaling Cat.# 3174S 
Mouse anti-PDGFRA, 1:200 BD Biosciences Cat.# 556001 
Goat anti-PDGFRA, 1:500 R&D Systems Cat.# AF-307-NA 
Rabbit anti-NG2, 1:100 Millipore Cat.# AB5320 
Rabbit anti-OLIG2, 1:500 Millipore Cat.# AB9610 
Mouse anti-OLIG2, 1:200 Millipore Cat.# MABN50 
Goat anti-OLIG2, 1:200 R&D Systems Cat.# AF2418 
Mouse anti-NKX2-2, 1:200 Abcam Cat.# ab187375 
Rabbit anti-EGFR, 1:500 Abcam Cat.# ab32077 
Sheep anti-EGFR, 1:500 Abcam Cat.# ab98133 
Mouse anti-SOX2, 1:300 BD Biosciences Cat.# 561506 
Goat anti-SOX2, 1:300 Santa Cruz Cat.# sc-17320 
Rabbit anti-PTPRZ1, 1:500 Atlas Antibodies Cat.# HPA015103 
Mouse anti-TNC, 1:100 Santa Cruz Cat.# sc-25328 
Rabbit anti-HOPX, 1:500 Proteintech Cat.# 11419-1-AP 
Rabbit anti-pS6, 1:300 Cell Signaling Cat.# 2211S 
Mouse anti-NES, 1:200 Millipore Cat.# MAB5326 
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Rat anti-GFAP, 1:1000 Invitrogen Cat.# 13-0300 
Chicken anti-VIM, 1:1000 Millipore Cat.# AB5733 
Mouse anti-pVIM (Ser55), 1:500 MBL Cat.# D076-3 
Mouse anti-pVIM (Ser82), 1:500 MBL Cat.# D095-3 
Sheep anti-EOMES, 1:300 R&D Systems Cat.# AF6166 
Rabbit anti-PPP1R17, 1:300 Atlas Antibodies Cat.# HPA047819 
Mouse anti-KI67, 1:200 Dako Cat.# M7240 
Chicken anti-GFP, 1:1000 Abcam Cat.# ab13970 
Rat anti-BrdU (CldU), 1:500 BIO-RAD Cat.# OBT0030G 
Mouse anti-ldU, 1:200 Sigma-Aldrich Cat.# SAB3701448 
Antibody for Blocking 
Sheep anti-PCDH15  Invitrogen Cat.# PA5-47865 
Bacterial and Virus Strains 
CMV-GFP adenovirus Vector Biolabs Cat. # 1060 
PCDH15-shRNA lenti-virus Origene Cat.# TL302649V 
DSCAM-shRNA lenti-virus Origene Cat.# TL304905V 
Chemicals, Peptides, and Recombinant Proteins 
Iressa Tocris Cat.# 3000 
AG1478 Tocris Cat.# 1276 
PD153035 Tocris Cat.# 1037 
LIF Peprotech Cat.# 300-05 
EGF Peprotech Cat.# 100-47 
PDGF Peprotech Cat.# 100-13A 
CNTF Peprotech Cat.# 450-13 
NT-3 Peprotech Cat.# 450-03 
Kits for Single-cell RNA-sequencing 
C1 Single-Cell Auto Prep Integrated Fluidic Circuit (Fluidigm) 
SMARTer Ultra Low RNA Kit (Clontech) 
Nextera XT DNA Sample Preparation Kit (Illumina) 
Chromium Chip B Single Cell Kit (10X Genomics) 
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CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents for resources and reagents 
should be directed to and will be fulfilled by the Lead Contact, Arnold R Kriegstein 
(Arnold.Kriegstein@ucsf.edu). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Embryonic Human Brain Tissue Samples 
De-identified tissue samples were collected with previous patient consent in strict observance 
of the legal and institutional ethical regulations from elective pregnancy termination specimens 
at San Francisco General Hospital. Protocols were approved by the Human Gamete, Embryo 
and Stem Cell Research Committee (institutional review board) at the University of California, 
San Francisco. Human brain tissue was transported to the laboratory within 2h of collection in 
artificial cerebrospinal fluid containing 125mM NaCl, 2.5mM KCl, 1mM MgCl2, 1mM CaCl2, 




Primary tissue samples were cut into 1cm3 pieces and fixed in 4% PFA in Ca2+/Mg2+ free 
PBS (pH=7.4) for 1h at room temperature or overnight at 4°C with constant agitation. After 
fixation, they were washed in PBS, equilibrated in 30% sucrose in PBS overnight at 4°C, 
embedded in blocks with a 1:1 mixture of 30% sucrose / OCT compound (Tissue-Tek, VWR) 
and frozen at -80°C. Blocks were frozen sectioned to a thickness of 16-20um cyosections. 
Antigen retrieval was performed if necessary, by heating section to 95°C in 10mM sodium 
citrate (pH=6) for 20min. Sections were then permeablized and blocked with 10% donkey 
serum in PBS with 0.1% Triton X-100 and 0.2% gelatin. Primary antibody incubations were 
performed at 4°C overnight, followed by three times of 10min PBS wash, and AlexaFluor 
secondary antibody (Thermo Fisher, 1:500 dilution) with DAPI incubations were performed at 
room temperature for 3hr. To detect thymidine analogs (BrdU, CldU or IdU), sections were 
denatured with 2N HCl for 1hr at room temperature followed by neutralization with 0.1M boric 
acid, and incubated with primary and secondary antibodies as described above. Slides were 
mounted with Aqua-mount (Lerner Laboratories). For quantitative analysis of cell numbers in 
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Figure S1-S4, samples were from 2 to 3 independent biological individuals, and 6 fields of 
microscrope images from each individual at each position (VZ/ISVZ/OSVZ/IZ/SP/CP) were 
included. For quantitative analysis of cell numbers in Figure 5B, 10 fields of microscrope 
images from each individual were included and the experiment was repeated in 3 independent 
biological individuals. 
 
Primary Cell Dissociation and Immunopanning 
Tissue samples were dissected in artificial cerebrospinal fluid using a microsurgical blade 
under a stereotaxic dissection microscope (Leica). To obtain single cell suspension, tissue 
samples were further cut into small pieces (<1mm3) and placed in a 6cm dish containing a pre-
warmed solution of Papain and DNase freshly diluted in Earl’s Balanced Salt Solution that was 
prepared according to the manufacturer protocol (Worthington Biochemical Corporation). After 
incubation at 37°C for 1h, tissue was centrifuged at 220g for 1 min to remove the 
Papain/DNase supernatant, washed with a OVO protease inhibitor stock solution. After 
centrifugation at 220g for 10min, and resuspension in Dulbecco’s Modified Eagle Medium / 
Nutrient Mixture F-12, tissue was further gently triturated by pipetting up and down 
approximately 10 times into a single cells suspension. The cell suspension was then added to 
a series of plastic Petri dishes pre-coated with cell-type-specific antibodies and incubated at 
37°C for 30min to 1h each. Unbound cells were transferred to the subsequent Petri dish; while 
the dish with bound cells was rinsed 10 times with DPBS to wash away loosely bound 
contaminating cell types. Bound cells were digested with 0.05% trypsin/EDTA, centrifuge at 
220g for 15min, and resuspended in corresponding medium.  
 
Primary Cell Culture 
Culture chamber slides were prepared by overnight coating with 0.01% poly-L-ornithine 
(Millipore Sigma) at 37°C. After three water washes, plates were coated with 5ug/ml laminin 
(Thermo Fisher) and 1ug/ml fibronectin (Corning) for 2hr. Single cell suspension was plated in 
the culture chamber slides at the concentration of 105/well for 8 well chambers or 2X105/well 
for 4 well chambers. Cells were cultured in the medium containing N2 supplement (1:100, 
Thermo FIsher), B27 supplement (1:50, Thermo Fisher), LIF (20ng/ml, Peprotech), EGF 
(20ng/ml, Peprotech), Insulin (5ug/ml, Sigma), Penicillin/Streptomycin (100U/ml) in 
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DMEM/F12+GlutamaxTM-I (Thermo Fisher) for the first 2 days, and then in the medium 
containing N2 supplement, B27 supplement, Insulin, NAC (5ug/ml, Sigma), Biotin (10ng/ml, 
Sigma), Trace Elements B (1000X, Thermo Fisher), CNTF (10ng/ml, Pepotech), PDGF 
(20ng/ml, Peprotech), NT-3 (1ng/ml, Peprotech), Penicillin/Streptomycin (100U/ml) in 
DMEM/F12+GlutamaxTM-I (Thermo Fisher) for the subsequent 5 or 8 days. Cells were 
incubated at 37°C, 5% CO2. For quantitative analysis of cell numbers in Figure 3C and S5C, 5 
fields of microscrope images from each individual were included and the experiment was 
repeated in 3 independent biological individuals. 
 
Primary Organotypic Slice Cultures 
Primary tissue samples were cut into 5mm thick pieces, and embedded in 3% low melting 
point agarose (Thermo Fisher) in artificial cerebrospinal fluid and sectioned into 250um using a 
Leica VT1200S vibrating blade microtome in artificial cerebrospinal fluid. Slices were then 
plated on Millicell inserts (Millipore) in the 6-well plate in the medium containing 60% Basal 
Medium Eagle (Thermo Fisher), 25% Hank’s BSS (Thermo Fisher), 10% FBS (Thermo Fisher), 
1% Penicillin/Streptomycin/Glutamine (Thermo Fisher), 1% N2 (Thermo Fisher), and 0.66% 
glucose. Slices were then cultured at 37°C, 5%CO2 and 8% O2 for up to 1 week. For 
pharmacological treatment assays, EGFR activator EGF was added into the slice culture 
medium at the final concentration of 50ng/ml [EGF(L)] or 200ng/ml [EGF(H)], while EGFR 
inhibitors Iressa, AG1478, and PD153035 were added into the slice culture medium at the final 
concentration of 50nM. For transplantation assays, primary cells were enriched by 
immunopanning, incubated with CMV-GFP adeno-virus for 1hr or shRNA lenti-virus for 3hr, 
washed in DPBS for twice, and injected into the cultured slices using a glass needle pipette. A 
total of 105 cells were evenly injected into 3 pieces of 1cm2 brain slices. For thymidine 
incubation assay, either CldU, IdU, or BrdU was added into the slice culture medium at the 
final concentration of 10nM for 12hr, and three iterations of PBS washing were performed after 
each thymidine treatment. For quantitative analysis of cell numbers in Figure 3D, 4E, and 7C, 
6 fields of microscrope images under each treatment from each individual were included and 
the experiment was repeated in 3 independent biological individuals. 
 
Time Lapse Image 
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After 2-3 days culture, GFP-expressing brain slices were transferred into glass-bottom plate 
with fresh medium, placed to an inverted Leica TCS SP5 with an on-stage incubator streaming 
5% CO2, 8% O2, balance N2 into the chamber. Slices were imaged for GFP using a 10X air 
objective (Zoom 2X) at 35 min intervals for up to 3 or 5 days with repositioning of the z-stacks 
every 24hr. For quantitative analysis in Figure 4D and 6DE, 30 cells from 2-3 independent 
biological individuals were pooled together. 
 
Single-cell RNA-sequencing 
For Fluidigm C1 scRNA-seq, cDNA synthesis and pre-amplification were performed as 
described before (Nowakowski et al., Science, 2017) using Fluidigm C1 auto-prep system 
following manufacturer’s protocol. After capture, microscope imaging was performed to identify 
wells with either debris or doublets and retain single-cell wells; these identifications were used 
in downstream analysis. Library preparation was performed using the llumina Nextera XT 
library preparation kit. Library concentration quantification was performed using Bioanalyzer 
(Agilent). Paired-end 100bp sequencing was performed on the Illumina HiSeq2500.  
For 10X Genomics scRNA-seq, target capture of 10,000 cells per sample was used; cDNA 
synthesis, pre-amplification and library preparation were performed as described before 
(Bhaduri et al., Nature, 2020) following manufacturer’s protocol “User Guide: Chromium Single 
Cell 3’ Reagent Kits (V3 Chemistry)”. Libraries from individual samples were pooled and 
sequenced on the NovaSeq 6000 machine. 
 
Alignment 
Trim Galore 3.7 was used to trim 20 bp of adaptor sequencing, and paired-end alignments 
were performed using HISAT2 to the human reference genome GRCh38. Counts for each cell 
were performed using subread-1.5.0 function featureCounts. After counts were obtained, 
normalization to counts per million was performed. Quality control was performed to further 
ensure that only high quality single cell data was processed further, and cells with fewer than 
1000 genes/cell were removed, as were cells with greater than 10% of their individual 
transcriptome represented in either mitochondrial or ribosomal transcripts. Only genes 
expressed in at least 30 cells were carried forward in the analysis.  
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Single-cell Clustering and Visualization 
Principal component analysis (PCA) was used to reduce the dimensionality of the dataset, and 
clustering was performed as previously described (Shekhar et al, 2016). In PC space, for each 
cell, the top 30 nearest neighbors were calculated for each cell using the ‘RANN’ R package 
nn2 function. The Jaccard distance, a weighted distance metric based upon the mutually 
shared neighbor sets for each pair of neighboring cells was calculated prior to clustering. With 
the Jaccard weighted distances, louvain clustering was performed using the ‘igraph’ R 
package. TSNE coordinates were calculated in PCA space (independent of the clusters). 
Differential expression to identify cluster markers was performed using the FindAllMarkers 
function in Seurat. The heatmap was generated using key marker genes in the space of a 
subset of clusters relevant to the analysis. The similarity matrix was calculated by correlating 
clusters to one another in principal component space.   
 
Monocle 
Monocle version 2 was used to generate the trajectory analysis. Excitatory neurons, IPCs, 
RGCs, and OPCs were extracted based upon the above clustering. These cells were re-
clustered as above and used as the input to Monocle. Differential gene expression for 
trajectory construction was performed using these cluster annotations, and metadata of broad 
cell type was used to color the plot. 
 
shRNA Efficiency Test  
HEK293T cells were plated in 12-well plates, and 200ng of cDNA vectors of PCDH15 
(NM_001142763.1, Sino Biological HG18931-UT) or DSCAM (NM_001271534.1, Sino 
Biological HG19944-UT) with 600ng of corresponding shRNA vectors were transfected into the 
cells using Lipofectamine 3000. Cells were harvested 48 hours after transfection for mRNA 
extraction using the RNAeasy micro plus kit. RNA quantity and quality were checked using 
NanoDrop 1000 (Thermo Scientific). qRT-PCR was performed using the ViiA 7 Real-time PCR 
System with PowerUp SYBR Green Master Mix, and analyzed with comparative Ct method 
normalized against the housekeeping gene GAPDH. Cells were harvested 72 hours after 
transfection for protein extraction. Cells were lysed with RIPA buffer (50 mM Tris-HCl pH 8.0, 
150 mM NaCl, 1 mM EDTA, 1 % NP-40, 0.5% sodium deoxycholate, 0.1% SDS) 
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supplemented with phosphatase and protease inhibitors (Roche). Lysates were homogenized 
by sonication followed by protein quantification via BCA assay (Pierce). LDS Sample buffer 
(Invitrogen) with a reducing agent was added to each lysate followed by a 10 min incubation at 
95°C. Samples were spun down and electrophoresed on a 4–12% Bis-Tris gel, transferred to a 
nitrocellulose membrane and blocked for one hour with Intercept (TBS) Protein-Free Blocking 
Buffer (LI-COR) prior to primary antibody incubation o/n. After 1-hour secondary antibody 
incubation the next day, membranes were imaged using an Odyssey Infrared Imager (LI-
COR). 
Additionally, OPCs were enriched by PDGFRA-immunopanning and cultured in 12-well plates 
(for qRT-PCR) or 6-well plate (for western blotting). When the cell density reached 80% of 
coverage, cells were infected with PCDH15-shRNA or DSCAM-shRNA lenti-viruses. OPCs 
were harvest three days after infection for qRT-PCR, or five days after infection for western 
blotting. 
 
Antibody Binding Test by FACS 
HEK293T cells were seeded into 6-well plates, and 1ug PCDH15 (NM_001142763.1, Sino 
Biological HG18931-UT), PCDH9 (Dharmacon OHS6085-213579205), or PCHD17 
(Dharmacon MHS6278-202801988) cDNA vectors were transfected into the cells using 
Lipofectamine 3000. For flow cytometry analysis to assay antibody specificity, cells were 
released 72 hours after cDNA transfection using PBS-EDTA (Lonza). 2 x 10^6 cells per 
condition were used for PCDH15 primary antibody (R&D systems AF6729, 1:40) staining in 
FACS staining buffer (D-PBS, 1% BSA, 2mM EDTA, 0.1% sodium azide) for 30 minutes on 
ice. Next, cells were washed in FACS staining buffer and incubated with Alexa Fluor 488 
conjugated secondary antibodies (Invitrogen, 1:400) for 30 minutes on ice. After final washes, 
Sytox Red (Invitrogen, 1:1000) was added to stain dead cells. Flow cytometry was carried out 
on an BD LSRFortessa X-20. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Quantification of images was performed using the Imaris Image Analysis software (Bitplane). 
Statistical analysis was performed using Microsoft Excel. Statistical tests, significance values, 
and experimental n are included in figure legends. All data are shown as mean ± SEM. In all 
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cases, p values are represented as follows: ***p<0.001, **p<0.01, *p<0.5, and N.S. when 
p>0.5. 
For quantitative analysis of cell numbers in Figure S1-S4, samples were from 2 to 3 
independent biological individuals, and 6 fields of microscrope images from each individual at 
each position (VZ/ISVZ/OSVZ/IZ/SP/CP) were included. For quantitative analysis of cell 
numbers in Figure 3C and S5C, 5 fields of microscrope images from each individual were 
included and the experiment was repeated in 3 independent biological individuals. For 
quantitative analysis of cell numbers in Figure 3D, 4E, and 7C, 6 fields of microscrope images 
under each treatment from each individual were included and the experiment was repeated in 
3 independent biological individuals. For quantitative analysis of cell numbers in Figure 5B, 10 
fields of microscrope images from each individual were included and the experiment was 
repeated in 3 independent biological individuals. For quantitative analysis in Figure 4D and 
6DE, 30 cells from 2-3 independent biological individuals were pooled together. 
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Figure S1. Co-staining of PDGFRA, OLIG2, and KI67, Related to Figure 3 and 5. 
(A) DAPI stained cortical slice with signposts showing how laminar regions were designated. 
(VZ: ventricular zone; ISVZ: inner subventricular zone; OSVZ: outer subventricular zone; IZ: 
intermediate zone; SP: subplate; CP: cortical plate.) 
(B) Quantification of PDGFRA+OLIG2+ OPC number in different cortical laminae at different 
time points in late second trimester, with KI67- cells in blue and KI67+ cells in red. At each 
stage (GW16/18/20/22/24), samples were from 2 to 3 individuals and 6 fields of microscropic 
images from each individual at each position (VZ/ISVZ/OSVZ/IZ/SP/CP) were included. 







Figure S2. Co-staining of EGFR, PDGFRA, and OLIG2, Related to Figure 3. 
(A) Representative images of EGFR, PDGFRA, and OLIG2 co-staining at GW22. 
(B) Distribution analysis of EGFR+PDGFRA+OLIG2+ cells across different cortical laminae at 
GW22. These triple labeled cells represent a transition stage from NPC to OPCs. Samples 
from 3 individuals and 6 fields of microscopic images from each individual at each position 




Figure S3. Co-staining of EGFR, OLIG2, and KI67, Related to Figure 3. 
(A) Quantification of EGFR+OLIG2+ Pre-OPC number in different cortical laminae at different 
time points in late second trimester, with KI67- cells in blue and KI67+ cells in red. At each 
stage (GW16/18/20/22/24), samples were from 2 to 3 individuals and 6 fields of microscopic 
images from each individual at each position (VZ/ISVZ/OSVZ/IZ/SP/CP) were included. 





Figure S4. Outer Radial Glia Cells Generate OPCs through EGFR-expressing Pre-OPCs. 
Related to Figure 3 and 4. 
(A) Characterization of cells co-expressing oRG and OPC markers. Images from human OSVZ 
at GW20-24 (n=3).  
(B) Characterization of cells co-expressing oRG markers and EGFR. Images from human 
OSVZ at GW20-24 (n=5).  
(C) Outline of immunopanning workflow (left). Cells were micro-dissected from human OSVZ. 
PDGFRA and O4 were used to deplete OPCs, and EGFR was used to deplete Pre-OPCs. 
LIFR positive selection enriched for oRGs. Images of marker staining at DIV2 and DIV10 
showing lineage progression (middle). Quantification of cell proportions (right). Mean±SD 




Figure S5. Co-staining of HOPX, EGFR, and OLIG2, Related to Figure 3. 
(A) Representative images of HOPX, EGFR, and OLIG2 co-staining at GW22. 
(B) Distribution analysis of HOPX+EGFR+OLIG2+ cells across different cortical laminae at 
GW22. These triple labeled cells represent a transition stage from oRGs to Pre-OPCs. 
Samples from 3 individuals and 6 fields of microscopic images from each individual at each 






Figure S6. Validation of Immunopanning Strategy. Related to Figure 4. 
(A) Feature plots of marker genes after 10X scRNA-seq. Cells were enriched by 
immunopanning and proliferative cells are indicated by MKI67 plots. 
(B) Heatmap showing differential gene expression between cells immunopanned by different 
antibodies. 
(C) Sample images of GFP virus infected cells enriched by immunopanning and transplanted 
to cultured cortical slices. 
(D) Trajectory analysis of different progenitors from 10X scRNA-seq using Monocle. Broad cell 







Figure S7. Validation of RNA Interference and Antibody Treatment. Related to Figure 6. 
(A) Validation of DSCAM-shRNA by RT-PCR and Western Blot. 
(B) Validation of PCDH15-shRNA by RT-PCR and Western Blot. 
(C) Validation of PCDH15-antibody extracellular-binding by FACS. 
(D) Time stamped still images of dividing OPCs treated with either IgG as control or PCDH15-
antibody to interfere with PCDH15 function. In each case, the control divisions resulted in 
repulsion between daughter cells. With PCDH15 interference, the daughter cells remained 





Figure S8. Representative Feature Plots of OPC-specific Genes and Cortical 
Malformation Related Genes. 
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Movie S1. Representative Video of an oRG Enriched by LIFR-panning. 
Related to Figure 4. 
 
Movie S2. Representative Video of a Pre-OPC Enriched by EGFR-panning. 
Related to Figure 4. 
 
Movie S3. Representative Video of an OPC Undergoing Two Rounds of Continuous 
Division. Related to Figure 5. 
 
Movie S4. Representative Video of an OPC Infected with Scramble-shRNA Lentivirus, 
Related to Figure 6. 
 
Movie S5. Representative Video of an OPC Infected with PCDH15-shRNA Lentivirus. 
Related to Figure 6. 
 
Movie S6. Representative Video of an OPC Treated with IgG. Related to Figure S7. 
 
Movie S7. Representative Video of an OPC Treated with PCDH15-antibody. Related to 
Figure S7. 
 
Movie S8. Representative Video of Two OPCs Encountering Each Other. Related to 
Figure 7. 
 
Movie S9. Representative Video of an OPC Infected with PCDH15-shRNA Lentivirus 
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